Vesper Bio is a clinical-stage biotechnology company.
Vesper Bio has raised $873K in total funding. The most recent round was Grant. The last funding was announced in January 2024.
Vesper Bio's investors include Michael J. Fox Foundation.
Vesper Bio is headquartered in Copenhagen, Denmark.
Vesper Bio is a clinical-stage biotechnology company.
Vesper Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vesper Bio — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/vesper-bio. Accessed August 14, 2026.
VCBacked. (2024). Vesper Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vesper-bio
{{cite web |title=Vesper Bio — Funding & Investors |url=https://www.vcbacked.co/company/vesper-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated